SignalCorporate
FDA adds rare vision-loss warning to popular GLP-1 drugs - AP News
FDA warning links GLP-1 drugs to rare vision loss, raising safety concerns.
What changed
FDA warning links GLP-1 drugs to rare vision loss, raising safety concerns.
Why it matters
FDA warning links GLP-1 drugs to rare vision loss, raising safety concerns. — impact context not separately stored; see What changed.
← Dashboard
Nov 11, 2026 07:12 AM ET